IMVT
Immunovant, Inc. · Healthcare
Chief Medical Officer Michael Geffner sold $94K of Immunovant, Inc.
Sold$94,243
$28.90Price
3,261Shares
−2%Stake
What IMVT did after the filing
- The stock from Fri, Apr 26 close, $27.17
- −6.5%
- S&P 500, same days
- +5.4%
Measured over 30 trading days, to the Jun 10 close.
Traded Wed, Apr 24. Filed Fri, Apr 26, 1:22 PM ET, during the session. Returns use the Apr 26 close and the Jun 10 close. Not investment advice.